The Two Health Care Cost Crises January 18, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman explores the nation’s twin health cost crises of affordability, especially for people who are sick and need a lot of health care, and national health spending, and why the solutions often work at cross purposes.
It’s Not a Health Care Election, But Health Issues Might Still Add Up February 28, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman explores the potential for some health care issues—including abortion, drug costs and other affordability challenges—to influence enough voters in swing states to make a difference in this year’s presidential election.
Forward or Backward on the Uninsured? April 25, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman looks back at the remarkable progress made in expanding coverage for the uninsured and what it could mean politically for today’s remaining uninsured—a population that has had little clout historically and will command even less attention now.
Family Health Insurance Is No Longer Affordable Through Small Employers November 28, 2023 From Drew Altman In his Beyond the Data column, KFF President and CEO Drew Altman discusses how how family health coverage is no longer affordable for workers at small employers, contributing to the health cost crisis affecting the American people.
Harris is Reframing Health as an Economic Issue August 21, 2024 From Drew Altman In his latest column, KFF President and CEO Drew Altman describes how Vice President Harris has reframed health as a pocketbook economic issue, which aligns with voters’ concern about health care costs.
How Many People with Employer-Sponsored Insurance Use the Drugs Slated for Medicare Price Negotiations August 14, 2024 Issue Brief Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the first 10 drugs identified for Medicare price negotiations, according to a new analysis. The most used drug for people with employer-sponsored health insurance was Jardiance, a drug used to treat diabetes and…
Insurer Strategies to Control Costs Associated with Weight Loss Drugs June 12, 2024 Issue Brief Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a an analysis of 2024 federal plan data. Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace prescription drug plans, compared to 82% of Marketplace prescription…
Why Affordability Is the Big Tent February 20, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman explores why the public’s concerns about out-of-pocket health costs make health care affordability the health policy issue most likely to resonate with voters across the political spectrum.
Health Reform Hits Main Street September 23, 2010 Video This short cartoon explains the problems with the current health care system, the health reform changes that are happening now, and the big changes coming in 2014 as part of the Affordable Care Act (ACA). You can view the video on our site and it is also available on YouTube.
Health Care Costs and Affordability May 28, 2024 Page This Health Policy 101 chapter explores trends in health care costs in the U.S. and the factors that contribute to this spending. It also examines how health care spending varies across the population, the impact of costs on care affordability and individuals’ overall financial vulnerability.